NO20032737L - Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av ivabradin - Google Patents

Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av ivabradin

Info

Publication number
NO20032737L
NO20032737L NO20032737A NO20032737A NO20032737L NO 20032737 L NO20032737 L NO 20032737L NO 20032737 A NO20032737 A NO 20032737A NO 20032737 A NO20032737 A NO 20032737A NO 20032737 L NO20032737 L NO 20032737L
Authority
NO
Norway
Prior art keywords
ivabradine
pharmaceutical composition
controlled release
thermoformable
solid
Prior art date
Application number
NO20032737A
Other languages
English (en)
Other versions
NO333776B1 (no
NO20032737D0 (no
Inventor
Patrick Wuethrich
Herve Rolland
Gilles Briault
Gerald Pichon
Francois Tharrault
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20032737L publication Critical patent/NO20032737L/no
Publication of NO20032737D0 publication Critical patent/NO20032737D0/no
Publication of NO333776B1 publication Critical patent/NO333776B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20032737A 2000-12-26 2003-06-16 Fast termoformbar farmasoytisk sammensetning for den kontrollerte frigivelse av ivabradin NO333776B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017015A FR2818552B1 (fr) 2000-12-26 2000-12-26 Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
PCT/FR2001/004134 WO2002051387A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Publications (3)

Publication Number Publication Date
NO20032737L true NO20032737L (no) 2003-06-16
NO20032737D0 NO20032737D0 (no) 2003-06-16
NO333776B1 NO333776B1 (no) 2013-09-16

Family

ID=8858190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032737A NO333776B1 (no) 2000-12-26 2003-06-16 Fast termoformbar farmasoytisk sammensetning for den kontrollerte frigivelse av ivabradin

Country Status (27)

Country Link
US (1) US20040028743A1 (no)
EP (1) EP1345594B1 (no)
JP (2) JP2004518665A (no)
KR (1) KR100542472B1 (no)
CN (1) CN1203844C (no)
AT (1) ATE352290T1 (no)
AU (1) AU2002228119B2 (no)
BR (1) BR0116548A (no)
CA (1) CA2432645A1 (no)
CY (1) CY1106390T1 (no)
CZ (1) CZ304587B6 (no)
DE (1) DE60126332T2 (no)
DK (1) DK1345594T3 (no)
EA (1) EA005814B1 (no)
ES (1) ES2280420T3 (no)
FR (1) FR2818552B1 (no)
HK (1) HK1060514A1 (no)
HU (1) HU229410B1 (no)
MX (1) MXPA03005840A (no)
NO (1) NO333776B1 (no)
NZ (1) NZ526406A (no)
PL (1) PL203835B1 (no)
PT (1) PT1345594E (no)
SI (1) SI1345594T1 (no)
SK (1) SK286413B6 (no)
WO (1) WO2002051387A1 (no)
ZA (1) ZA200304441B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
GB2418854B (en) 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
FR2882553B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2010128525A2 (en) * 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
EP2579860B1 (en) 2010-06-14 2014-04-23 Ratiopharm GmbH Ivabradine-containing pharmaceutical composition with modified release
CN101897682B (zh) * 2010-07-13 2012-02-15 石药集团欧意药业有限公司 一种伊伐布雷定或其可药用盐固体制剂及其制备方法
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
EP3082772A1 (en) * 2013-12-20 2016-10-26 Synhton B.V. Pharmaceutical composition comprising amorphous ivabradine
EP3025705B8 (en) 2014-11-25 2018-11-28 Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi Stable ivabradine formulations
CN104398486B (zh) * 2014-12-08 2018-01-12 武汉武药科技有限公司 一种盐酸伊伐布雷定渗透泵控释片及其制备方法
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH11514979A (ja) * 1995-09-07 1999-12-21 フイズ テクノロジーズ リミテッド 実質的に非溶解性の生体作用薬剤をバイオ・アベイラブルにするシステム
WO1999009957A1 (en) * 1997-08-26 1999-03-04 Hoechst Marion Roussel, Inc. Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
DE19901040A1 (de) * 1999-01-14 2000-07-20 Knoll Ag Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Also Published As

Publication number Publication date
MXPA03005840A (es) 2003-09-10
EP1345594B1 (fr) 2007-01-24
FR2818552A1 (fr) 2002-06-28
HUP0302522A2 (hu) 2003-12-29
PL203835B1 (pl) 2009-11-30
NZ526406A (en) 2005-08-26
CN1203844C (zh) 2005-06-01
CZ304587B6 (cs) 2014-07-23
JP2004518665A (ja) 2004-06-24
US20040028743A1 (en) 2004-02-12
DE60126332D1 (de) 2007-03-15
CA2432645A1 (fr) 2002-07-04
SK286413B6 (sk) 2008-09-05
ZA200304441B (en) 2004-06-25
SI1345594T1 (sl) 2007-04-30
NO333776B1 (no) 2013-09-16
EP1345594A1 (fr) 2003-09-24
DE60126332T2 (de) 2007-08-30
PT1345594E (pt) 2007-04-30
DK1345594T3 (da) 2007-05-21
CY1106390T1 (el) 2011-10-12
ES2280420T3 (es) 2007-09-16
HU229410B1 (en) 2013-12-30
FR2818552B1 (fr) 2003-02-07
WO2002051387A1 (fr) 2002-07-04
ATE352290T1 (de) 2007-02-15
PL361662A1 (en) 2004-10-04
AU2002228119B2 (en) 2006-04-27
SK9422003A3 (en) 2003-12-02
WO2002051387A8 (fr) 2004-05-13
HK1060514A1 (en) 2004-08-13
KR20030064876A (ko) 2003-08-02
BR0116548A (pt) 2003-12-23
HUP0302522A3 (en) 2007-09-28
EA200300667A1 (ru) 2003-12-25
EA005814B1 (ru) 2005-06-30
NO20032737D0 (no) 2003-06-16
KR100542472B1 (ko) 2006-01-11
CZ20032020A3 (cs) 2003-11-12
JP2010100641A (ja) 2010-05-06
CN1482901A (zh) 2004-03-17

Similar Documents

Publication Publication Date Title
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
NO20032737D0 (no) Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av ivabradin
SG152240A1 (en) Pharmaceutical compositions comprising an amphiphilic starch
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
DK1861073T4 (da) Fremgangsmåde til fremstilling af calciumsammensætninger i en kontinuerlig fluid bed
AU2002212894A1 (en) N-type calcium channel antagonists for the treatment of pain
EA200501901A1 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путём
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
ES2168855T3 (es) Composiciones farmaceuticas en forma de microparticulas polimericas obtenidas por extrusion y esferoidizacion.
AU2002228119A1 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
EA200201149A1 (ru) Фармацевтические композиции и способы для предотвращения рецидива мигрени
EA200300664A1 (ru) Твердая термоформируемая фармацевтическая композиция для контролируемого высвобождения периндоприла
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
YU35303A (sh) Preparati n-(1-metiletilaminokarbonil)-4-(3-metilfenil-amino)-3-piridinsulfonamida i cikličnih oligosaharida
AR032049A1 (es) Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa
WO2004069228A3 (en) Sustained release formulations of venlafaxine
NO20052480D0 (no) Utvidede farmasoytiske sammensetninger med kontrollert frigjoring omfattende ladede polymerer.
ATE415150T1 (de) Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin- antibiotikum
WO2004100931A3 (en) Use of soaps such as magnesium stearate for increasing the release of drugs

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees